Cyprotex, a clinical research firm specialising in the preclinical evaluation of the absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of drug candidates, is to grow its US presence by acquiring toxicology expert Apredica. According to Cyprotex, this ...
Please Login to read the full article.
